FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia

(5:1econd)

FDA D.I.S.C.O.: FDA approval of cabozantinib for hepatocellular carcinoma

(5:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Ryoncil (remestemcel-L-rknd) for steroid-refractory...

(3:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Omisirge (omidubicel-onlv) to reduce time to neutro...

(3:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of ABECMA (idecabtagene vicleucel) the first FDA appro...

(3:31)

FDA D.I.S.C.O.: A new drug approval for IDH1 positive relapsed or refractory Acute Myeloid Leukemia

(6:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Trodelvy (sacituzumab govitecan-hziy) for HR-positi...

(4:1econd)

#LaJuntaNews T2E62 | ¿Es difícil ser exótico en un país hater como Chile? junto a @JAMEZMANUEL

(1:3:3)

Understand the Applicability of FDA’s Computer Software Assurance Guidance to Data Integrity

(1:6:45)

January 10, 2025 Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) Meeting

(7:49:20)

Can Metformin Really Add Years to Your Life?

(17:21)

FDA D.I.S.C.O. Burst Edition: FDA approval of Ojemda (tovorafenib) for relapsed or refractory ped...

(4:1econd)

Navigating FDA's Drug Information Resources

(50:52)

Congressional Hearing with the FDA

(9:52)

An Overview of FDA's Project Facilitate Oncology Expanded Access Program

(50:9)

FDA Drug Topics - FDA Drug Information Resources and Applicability to Health Care Professionals

(52:15)

The Federal Plan to Monetize Sunlight, Bee Pollination on Your Land | Facts Matter

(41:21)

FDA D.I.S.C.O.: First FDA approval of a CAR T-cell immunotherapy

(6:1econd)

30 Day FDA and ICH Drug Development Regulations - Day 0 Introduction

(17:43)

FDA D.I.S.C.O.: Intro by Dr. Richard Pazdur

(3:21)

FDA D.I.S.C.O. Burst Edition: FDA approval of Lynparza (olaparib), with abiraterone and prednison...

(3:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Brukinsa (zanubrutinib) for adult patients with Wal...

(3:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Fruzaqla (fruquintinib) for adult patients with met...

(3:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Epkinly (epcoritamab-bysp) for relapsed or refracto...

(3:31)

FDA D.I.S.C.O.: First biosimilar approval for the treatment of cancer

(8:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Verzenio (abemaciclib) with endocrine therapy for p...

(4:31)

FDA D.I.S.C.O.: FDA approval of Cablivi for acquired thrombotic thrombocytopenic purpura

(8:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for the adjuvant treatment...

(3:31)

FDA D.I.S.C.O.: FDA approval of moxetumomab pasudotox-tdfk for relapsed or refractory hairy cell ...

(6:31)

FDA D.I.S.C.O.: First Tissue/Site Agnostic Approval Transcript

(6:1econd)